WallStSmart

Aspire BioPharma, Inc. (ASBP)vsO’Reilly Automotive Inc (ORLY)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

O’Reilly Automotive Inc generates 19017473% more annual revenue ($18.57B vs $97,660). ORLY leads profitability with a 14.3% profit margin vs 0.0%. ORLY earns a higher WallStSmart Score of 64/100 (C+).

ASBP

Avoid

22

out of 100

Grade: F

Growth: 4.3Profit: 4.5Value: 5.0Quality: 5.3
Piotroski: 3/9Altman Z: -83.49

ORLY

Buy

64

out of 100

Grade: C+

Growth: 6.0Profit: 8.0Value: 6.7Quality: 5.0
Piotroski: 3/9Altman Z: 1.42
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for ASBP.

ORLYUndervalued (+75.3%)

Margin of Safety

+75.3%

Fair Value

$364.65

Current Price

$90.44

$274.21 discount

UndervaluedFair: $364.65Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ASBP1 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

ORLY4 strengths · Avg: 9.3/10
Return on EquityProfitability
58.6%10/10

Every $100 of equity generates 59 in profit

Debt/EquityHealth
-5.2210/10

Conservative balance sheet, low leverage

Market CapQuality
$72.22B9/10

Large-cap with strong market position

Operating MarginProfitability
20.2%8/10

Strong operational efficiency at 20.2%

Areas to Watch

ASBP4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$11.80M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

ORLY4 concerns · Avg: 3.3/10
PEG RatioValuation
1.614/10

Expensive relative to growth rate

P/E RatioValuation
28.3x4/10

Moderate valuation

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.422/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : ASBP

The strongest argument for ASBP centers on Price/Book.

Bull Case : ORLY

The strongest argument for ORLY centers on Return on Equity, Debt/Equity, Market Cap.

Bear Case : ASBP

The primary concerns for ASBP are Revenue Growth, EPS Growth, Market Cap.

Bear Case : ORLY

The primary concerns for ORLY are PEG Ratio, P/E Ratio, Piotroski F-Score.

Key Dynamics to Monitor

ORLY carries more volatility with a beta of 0.54 — expect wider price swings.

ORLY is growing revenue faster at 8.1% — sustainability is the question.

ORLY generates stronger free cash flow (699M), providing more financial flexibility.

Monitor AUTO PARTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ORLY scores higher overall (64/100 vs 22/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Aspire BioPharma, Inc.

CONSUMER CYCLICAL · AUTO PARTS · USA

Aspire Biopharma Holdings, Inc., early-stage biopharmaceutical company, engages in developing and marketing of disruptive technology for delivery mechanisms for do no harm drugs in the United States. The company is headquartered in Humacao, Puerto Rico.

Visit Website →

O’Reilly Automotive Inc

CONSUMER CYCLICAL · AUTO PARTS · USA

O'Reilly Auto Parts is an American auto parts retailer that provides automotive aftermarket parts, tools, supplies, equipment, and accessories in the United States serving both the professional service providers and do-it-yourself customers.

Want to dig deeper into these stocks?